Therapies

  • telomeres
    Research will focus on improving the lives of people with Down syndrome The BioFrontiers Institute at the University of Colorado launched its inaugural Sie Post-doctoral Fellowship Program in affiliation with the Linda Crnic Institute for Down
  • Robin Dowell collaborated with MCDB's Joaquin Espinosa and Mary Allen (pictured below) to make sense of p53.
    A major collaboration of Colorado institutions uses new technology to show, after more than 30 years and 50,000 papers on the subject, the direct targets of the gene p53, the most potent “tumor suppressor” gene. The finding is a strong step toward
  • Leslie Leinwand is looking for new ways to treat pediatric heart disease.
    The motor protein, myosin, has fascinated BioFrontiers Chief Scientific Officer Leslie Leinwand for more than 25 years. This protein is responsible for making muscles contract in the body, but Leinwand, a professor in molecular, cellular and
  • A cardiomyocyte imaged by the BioFrontiers Advanced Imaging Facility.
    BioFrontiers scientist tackles a childhood disease of the heartBioFrontiers Chief Scientific Officer Leslie Leinwand, has been studying the motor protein, myosin, for 25 years. This important protein is responsible for making muscles contract,
  • Leslie Leinwand, MCDB Professor and BioFrontiers Intitute Chief Scientific Officer
    CU professor co-founds new company to develop genetic heart disease treatmentA new biomedical company involving the University of Colorado Boulder, Stanford University and the Harvard Medical School has been launched with $38 million in financing
  • Telomeres sit at the ends of chromosomes to protect their genetic data. Credit: Jane Ades, NHGRI
    In a new paper released today in Nature, BioFrontiers Institute scientists at the University of Colorado in Boulder, Tom Cech and Leslie Leinwand, detailed a new target for anti-cancer drug development that is sitting at the ends of our
  • Biofrontiers scientist, Hubert Yin, is focused on making morphine more effective and less addictive.
    A University of Colorado Boulder-led research team has discovered that two protein receptors in the central nervous system team up to respond to morphine and cause unwanted neuroinflammation, a finding with implications for improving the efficacy of
  • Biofrontiers scientist, Leslie Leinwand holds a Burmese python in her lab. Image by: Thomas Cooper
    On Science Friday: Leslie Leinwand discusses the Python Project On December 9, Biofrontiers Institute's Chief Scientific Officer Leslie Leinwand shared some scaly tales of her research with Burmese pythons on NPR's Science Friday. During the
  • Biofrontiers Institute scientist, Hang (Hubert) Yin’s, focus on the Epstein Barr virus is leading him to a greater understanding of how cancer invades cells. Photo courtesy: Glenn Asakawa, University of Colorado Boulder
    Stopping cancer's knock on the doorAs a self-proclaimed “science nerd” in a Beijing high school, Hubert Yin considered biochemistry to be the ultimate in cool. It was the only science, he felt, that was capable of explaining what he thought was the
  • Biofrontiers scientist, Leslie Leinwand holds a Burmese python in her lab. Image by: Thomas Cooper
    Pythons provide clues to human heart health A surprising new University of Colorado Boulder study shows that huge amounts of fatty acids circulating in the bloodstreams of feeding pythons promote healthy heart growth, results that may have
Subscribe to Therapies